Ledger.Open graph →
SEC Form D · Amendment · filed March 14, 2013

Valence Advantage Life Sciences Fund II, L.P

Offering
$175.0M
Sold
$60.8M
Exemption
—
Industry
Pooled Investment Fund
Location
NEW YORK, NY
Type
Pooled fund

People & firms on this filing (9)

Scott R. Morenstein · New York, NYDirectorJay R. Cecil · New York, NYDirectorA. R. Leheny · New York, NYDirectorValence Life Sciences Gp Ii, Llc · New York, NYPromoterRoger H. Hanson · Grand Cayman, Cayman IslandsDirectorBarry J. Giarraputo · New York, NYDirectorJoseph D. Glatt · New York, NYDirectorJoshua J. Harris · New York, NYDirectorValence Life Sciences Gp Ii, Llc · New York, NYPromoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗